A recent study shows that FOXO1 silencing using small interfering ribonucleic acid (siRNA) in hepatocellular carcinoma enhances mesenchymal and reduces epithelial marker expression, as in EMT [55]. Here, FOXO1 is linked to hepatocellular carcinoma.